TSS
NVRO

Two Sigma Securities’s NEVRO CORP. NVRO Stock Holding History

Two Sigma Securities’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,300
Closed -$178K – 3817
2024
Q1 		$178K Sell
12,300
-10,200
-45% -$169K ﹤0.01% 2368
2023
Q4 		$484K Buy
+22,500
New +$401K ﹤0.01% 1582
2022
Q4 		– Sell
-8,200
Closed -$382K – 3380
2022
Q3 		$382K Buy
+8,200
New +$381K 0.01% 1340

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Securities's NVRO Position: Q4 2018 in Review

Two Sigma Securities sold out of NEVRO CORP. (NVRO) in Q4 2018, closing a stake of 3,736 shares — an estimated $213K sold.

Two Sigma Securities first reported a position in NVRO in Q3 2018 and held it in 1 quarter. The position peaked at $213K in Q3 2018. 157 funds tracked by Wall St. Rank hold NVRO as of Q4 2018.

  • Two Sigma Securities reported no remaining NEVRO CORP. position as of Q4 2018 after selling out during the quarter.
  • Two Sigma Securities sold 3,736 NEVRO CORP. shares in Q4 2018, an estimated $213K.
  • Two Sigma Securities first reported a position in NEVRO CORP. in Q3 2018 and held it in 1 quarter.
  • Two Sigma Securities's NEVRO CORP. position peaked at $213K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2018.

Based on Two Sigma Securities's 13F filing for Q4 2018, filed 14 Feb 2019.